title: More about imatinib and nilotinib combination therapy in chronic myeloid leukemia.
authors.forename: David
authors.initials: D
authors.lastname: Gómez-Almaguer
authors.forename: Luz
authors.initials: L
authors.lastname: Tarín-Arzaga
authors.forename: Olga
authors.initials: O
authors.lastname: Cantú-Rodríguez
authors.forename: Adrián
authors.initials: A
authors.lastname: Ceballos-López
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001752:Blast Crisis / Q000188:drug therapy*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D010879:Piperazines; D011743:Pyrimidines